Vorikonazol PharmaS 200 mg prašak za otopinu za infuziju Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

vorikonazol pharmas 200 mg prašak za otopinu za infuziju

pharmas d.o.o., radnička cesta 47, zagreb, hrvatska - vorikonazol - prašak za otopinu za infuziju - 200 mg - urbroj: svaka bočica sadrži 200 mg vorikonazola

Abirateron Alpha-Medical 500 mg filmom obložene tablete Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

abirateron alpha-medical 500 mg filmom obložene tablete

alpha-medical d.o.o., dragutina golika 36, zagreb, hrvatska - abirateronacetat - filmom obložena tableta - urbroj: svaka tableta sadrži 500 mg abirateronacetata

Duavive Europska Unija - hrvatski - EMA (European Medicines Agency)

duavive

pfizer europe ma eeig - estrogeni sjedinjen, bazedoxifene - postmenopauzi - sjedinjen estrogena i bazedoxifene - duavive indiciran za:liječenje simptoma nedostatka estrogena kod žena u menopauzi s maternice (ne manje od 12 mjeseci od dana posljednje menstruacije), za koje je terapija s progestina koji sadrže terapija ne odgovara. iskustva iz tretmana žena u dobi iznad 65 godina je ograničena.

UNISTRAIN PRRS Hrvatska - hrvatski - Ministarstvo poljoprivrede, Uprava za Veterinarstvo i sigurnost hrane

unistrain prrs

laboratorios hipra, s.a., avda. la selva, 135, 17170 amer (girona), Španjolska - živi atenuirani virus reproduktivnog i respiratornog sindroma svinja (engl. porcine reproductive and respiratory sydrome virus, prrsv), soj vp-046 bis - liofilizat i otapalo za suspenziju za injekciju - živo virusno cjepivo, virusno cjepivo protiv reproduktivnog i respiratornog sindroma svinja (engl. porcine reproductive and respiratory syndrome, prrs) - svinja

Distraneurin 192 mg meke kapsule Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

distraneurin 192 mg meke kapsule

medis adria d.o.o., kolarova 7, zagreb - clomethiazolum - kapsula, meka - 192 mg - urbroj: jedna meka kapsula sadrži 192 mg klometiazola

Mvabea Europska Unija - hrvatski - EMA (European Medicines Agency)

mvabea

janssen-cilag international n.v.    - recombinant modified vaccinia ankara bavarian nordic virus encoding the: ebola virus zaire (zebov) mayinga strain glycoprotein (gp); ebola virus sudan gulu strain gp; ebola virus taï forest strain nucleoprotein and the marburg virus musoke strain gp - Геморрагическая groznice ebole - cjepiva - active immunization for prevention of disease caused by ebola virus (zaire ebolavirus species) in individuals ≥ 1 year of age.

Teysuno Europska Unija - hrvatski - EMA (European Medicines Agency)

teysuno

nordic group b.v. - тегафур, gimeracil, oteracil - neoplazme želuca - antineoplastična sredstva - teysuno is indicated in adults:- for the treatment of advanced gastric cancer when given in combination with cisplatin (see section 5. - as monotherapy or in combination with oxaliplatin or irinotecan, with or without bevacizumab, for the treatment of patients with metastatic colorectal cancer for whom it is not possible to continue treatment with another fluoropyrimidine due to hand-foot syndrome or cardiovascular toxicity that developed in the adjuvant or metastatic setting.

Faslodex Europska Unija - hrvatski - EMA (European Medicines Agency)

faslodex

astrazeneca ab - fulvestrant od - neoplazme dojki - endokrini terapija, anti-estrogeni - faslodex is indicated , as monotherapy for the treatment of estrogen receptor positive, locally advanced or metastatic breast cancer in postmenopausal women:, , not previously treated with endocrine therapy, or, with disease relapse on or after adjuvant antiestrogen therapy, or disease progression on antiestrogen therapy. , , , in combination with palbociclib for the treatment of hormone receptor (hr)-positive, human epidermal growth factor receptor 2 (her2)-negative locally advanced or metastatic breast cancer in women who have received prior endocrine therapy. u pre - ili perimenopauzi, u sveobuhvatnoj liječenju s palbociclib treba kombinirati s luteinizirajućeg hormona releasing hormon (lhrh) agonist.